Ozlen Konu et al. also reported that CHRNA5 silencing in breast cancer significantly inhibited tumor growth, which might be attributed to the significant inhibition of cell-cycle-associated genes after CHRNA5 silencing [34]. This evidence concerns the gene CHRNA5 and breast cancer.